Last data update: Oct 10, 2019. (Total: 2661 publications since 2011)
|Query Trace: all>>Richard S Olney[CDC Author]|
| Detection of critical congenital heart defects: Review of contributions from prenatal and newborn screening.
Richard S Olney, Elizabeth C Ailes, and Marci K Sontag
Semin. Perinatol. 2015 Apr 39(3) 230-7
| A public health economic assessment of hospitals' cost to screen newborns for critical congenital heart disease.
Cora Peterson, Scott D Grosse, Jill Glidewell, Lorraine F Garg, Kim Van Naarden Braun, Mary M Knapp, Leslie M Beres, Cynthia F Hinton, Richard S Olney, and Cynthia H Cassell
Public Health Rep 129(1) 86-93
| Developing a public health-tracking system for follow-up of newborn screening metabolic conditions: a four-state pilot project structure and initial findings.
Cynthia F Hinton, Cara T Mai, Sarah K Nabukera, Lorenzo D Botto, Lisa Feuchtbaum, Paul A Romitti, Ying Wang, Kimberly Noble Piper, and Richard S Olney
Genet. Med. 2014 Jun 16(6) 484-90
| Frequency of prenatal cytogenetic diagnosis and pregnancy outcomes by maternal race-ethnicity, and the effect on the prevalence of trisomy 21, Metropolitan Atlanta, 1996-2005.
Jodi M Jackson, Krista S Crider, Janet D Cragan, Sonja A Rasmussen, and Richard S Olney
Am. J. Med. Genet. A 2014 Jan 164A(1) 70-6
| Newborn screening for critical congenital heart disease: essential public health roles for birth defects monitoring programs.
Richard S Olney, and Lorenzo D Botto
Birth Defects Res. Part A Clin. Mol. Teratol. 2012 Dec 94(12) 965-9
| Trends in cytogenetic testing and identification of chromosomal abnormalities among pregnancies and children with birth defects, metropolitan Atlanta, 1968-2005.
Jodi M Jackson, Krista S Crider, Sonja A Rasmussen, Janet D Cragan, and Richard S Olney
Am. J. Med. Genet. A 2012 Jan 158A(1) 116-23